Please provide your email address to receive an email when new articles are posted on . Men prescribed long-acting testosterone undecanoate injections had a higher adherence to therapy at 1 year ...
Please provide your email address to receive an email when new articles are posted on . Testosterone undecanoate injected at 8-week intervals for men with hypogonadism may reduce fluctuations and ...
NEW YORK (Reuters Health) - A new oral testosterone undecanoate formulation can restore testosterone concentrations to normal in hypogonadal men, researchers report. "Effective as other testosterone ...
MIAMI -- Oral testosterone replacement therapy (TRT) seemed safe and effective in men with testosterone deficiency, according to a meta-analysis. Among nine studies that looked at changes in serum ...
SAN DIEGO -- Long-term testosterone therapy was associated with sustained reductions in weight for men with hypogonadism and class III obesity, a researcher reported. In registry data on 76 patients, ...
The approval was based on data from a phase 3 study that evaluated the efficacy and safety of Tlando in 95 adult hypogonadal male patients. The Food and Drug Administration (FDA) has approved Tlando™ ...
The FDA has approved Kyzatrex (testosterone undecanoate) for the treatment of primary and secondary hypogonadism in adult males. The Food and Drug Administration (FDA) has approved Kyzatrex ™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results